https://adisinsight.springer.com/drugs/800049874?error=cookies_not_supported&code=5451051e-1897-4d63-8e94-f61ddb4d6df9
Botulinum toxin - OBIGEN PHARMA - AdisInsight
OBIGEN PHARMA (Dingjin Biotech) (Subsidiary of OBI Pharma) is developing a formulation of botulinum toxin, designated as OBI 858, for the treatment of glabellar
botulinum toxinpharmaadisinsight